# Terumo Blood and Cell Technologies receives $10.6M contract for freeze-dried plasma development

Terumo Blood and Cell Technologies received a $10.6 million contract from MTEC, sponsored by the U.S. Defense Health Agency, to continue development of freeze-dried plasma.

- Type: Contract
- Announced: 2022-04-26
- Where: United States
- Value: $10.6M
- Status: announced
- Products: freeze-dried plasma
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Terumo](https://endata.com/companies/2811.md)
- [Medical Technology Enterprise Consortium](https://endata.com/companies/62506.md) (customer)
- [U.S. Army Medical Research and Development Command](https://endata.com/companies/62507.md) (customer)
- [Defense Health Agency](https://endata.com/companies/62508.md) (customer)
- [Naval Medical Research Center](https://endata.com/companies/62509.md) (customer)

## Sources

- [terumo.com](https://www.terumo.com/newsrelease/detail/20220426/5211), 2022-04-26: "The latest round of funding will further advance the company's product development, Makam said."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
